glp 1 anorexia nervosa GLP-1RAs and Obesity Associated with Eating Disorders GLP-1s and Binge Eating Disorder:

Administered as a once-weekly subcutaneous injection, tirzepatide has demonstrated significant efficacy in glycemic control and weight reduction in clinical trials

Importantly, depressions in postprandial lipoprotein metabolism via central GLP-1R activation were mediated via increased sympathetic outflow, as pharmacological blockade abolished the effects of ICV GLP-1

Even if the vial or pen still feels cold, visual changes mean the peptide structure has likely been compromised and the medication should not be used

Zhang L, Li L, Yang M, Xu K, Boden G, Yang G

What were the findings of the LEADER trial and their implications for patients with type II diabetes and high cardiovascular risk

Ozempic Risk Management Plan (PDF)